Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.3946
-0.0037 (-0.93%)
Apr 25, 2025, 12:03 PM EDT - Market open

Applied Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-105.62-119.76-82.51-105.58-93.96
Upgrade
Depreciation & Amortization
0.430.350.440.420.38
Upgrade
Stock-Based Compensation
13.477.369.611.188.03
Upgrade
Other Operating Activities
4.9158.323.213.88-0.36
Upgrade
Change in Accounts Payable
2.69-2.79-4.938.82-8.04
Upgrade
Change in Other Net Operating Assets
-0.171.35-3.92-9.4415.75
Upgrade
Operating Cash Flow
-84.31-55.17-78.09-90.73-78.21
Upgrade
Investment in Securities
-13.8713.1712.43-19.47
Upgrade
Investing Cash Flow
-13.8713.1712.43-19.47
Upgrade
Short-Term Debt Repaid
-0.31-1.86-3.27-4.72-2.15
Upgrade
Total Debt Repaid
-0.31-1.86-3.27-4.72-2.15
Upgrade
Net Debt Issued (Repaid)
-0.31-1.86-3.27-4.72-2.15
Upgrade
Issuance of Common Stock
114.1274.8527.8675.17136.66
Upgrade
Other Financing Activities
-1.553.114.271.78
Upgrade
Financing Cash Flow
113.8174.5427.6974.72136.29
Upgrade
Net Cash Flow
29.533.24-37.23-3.5838.62
Upgrade
Levered Free Cash Flow
-92.517.74-33.86-50.75-43.09
Upgrade
Unlevered Free Cash Flow
-92.517.74-33.86-50.75-43.09
Upgrade
Change in Net Working Capital
43.31-40.36-7.94-3.67-7.55
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q